Literature DB >> 34295697

Long non-coding RNA SENCR alleviates hypoxia/reoxygenation-induced cardiomyocyte apoptosis and inflammatory response by sponging miR-1.

Minghe Chen1, Yini Guo2, Zongli Sun1, Xiangjiang Meng1.   

Abstract

BACKGROUND: Myocardial cell apoptosis is one of the main reasons for the occurrence of acute myocardial infarction (AMI). The role of smooth muscle and endothelial cell enriched migration/differentiation-associated lncRNA (SENCR) in the cardiomyocyte apoptosis induced by hypoxia/reoxygenation (H/R) injury and its potential mechanism were investigated in this study to provide a novel biomarker for the development of AMI.
METHODS: The expression levels of SENCR in the serum of AMI patients and non-AMI patients with chest pain (control) were detected by qRT-PCR. The function of SENCR in the cardiomyocyte apoptosis and inflammatory response induced by H/R injury was evaluated by MTT, cell apoptosis, and ELISA assay, respectively. The mechanism underlying the function of SENCR was investigated with the luciferase reporter assay.
RESULTS: SENCR was significantly downregulated in AMI compared with the control volunteers, which showed negative correlations with the cardiac troponin I (cTnI) and creatine kinase-MB (CK-MB) level of patients. The H/R injury-induced cell apoptosis and inflammatory response in cardiomyocytes, which were attenuated by the overexpression of SENCR. The expression of miR-1 was suppressed by the overexpression of SENCR, while the overexpression of miR-1 could alleviate the cell apoptosis, enhance cell viability, and attenuate inflammatory response in cardiomyocyte. SENCR reversed H/R-induced myocardial cell injury by regulating the expression of miR-1.
CONCLUSIONS: SENCR was correlated with the clinicopathological features of patients and was revealed to alleviate the cardiomyocyte apoptosis and inflammatory response induced by H/R injury via sponging miR-1. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Smooth muscle and endothelial cell enriched migration/differentiation-associated lncRNA (SENCR); acute myocardial infarction (AMI); hypoxia/reoxygenation injury (H/R injury); miR-1

Year:  2021        PMID: 34295697      PMCID: PMC8261747          DOI: 10.21037/cdt-20-1037

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  26 in total

1.  Inhibition of the Cardiac Fibroblast-Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction.

Authors:  Maria-Teresa Piccoli; Shashi Kumar Gupta; Janika Viereck; Ariana Foinquinos; Sabine Samolovac; Freya Luise Kramer; Ankita Garg; Janet Remke; Karina Zimmer; Sandor Batkai; Thomas Thum
Journal:  Circ Res       Date:  2017-06-19       Impact factor: 17.367

2.  SERS-based immunoassay using gold-patterned array chips for rapid and sensitive detection of dual cardiac biomarkers.

Authors:  Ziyi Cheng; Rui Wang; Yanlong Xing; Linlu Zhao; Jaebum Choo; Fabiao Yu
Journal:  Analyst       Date:  2019-11-04       Impact factor: 4.616

Review 3.  Acute myocardial infarction.

Authors:  Stephen Boateng; Timothy Sanborn
Journal:  Dis Mon       Date:  2013-03       Impact factor: 3.800

4.  Contemporary risk model for inhospital major bleeding for patients with acute myocardial infarction: The acute coronary treatment and intervention outcomes network (ACTION) registry®-Get With The Guidelines (GWTG)®.

Authors:  Nihar R Desai; Kevin F Kennedy; David J Cohen; Traci Connolly; Deborah B Diercks; Mauro Moscucci; Stephen Ramee; John Spertus; Tracy Y Wang; Robert L McNamara
Journal:  Am Heart J       Date:  2017-08-12       Impact factor: 4.749

5.  Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA.

Authors:  Robert D Bell; Xiaochun Long; Mingyan Lin; Jan H Bergmann; Vivek Nanda; Sarah L Cowan; Qian Zhou; Yu Han; David L Spector; Deyou Zheng; Joseph M Miano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-27       Impact factor: 8.311

Review 6.  Atherosclerosis and inflammation: overview and updates.

Authors:  Glaucylara Reis Geovanini; Peter Libby
Journal:  Clin Sci (Lond)       Date:  2018-06-21       Impact factor: 6.124

7.  Value of circulating miRNA-1 detected within 3 h after the onset of acute chest pain in the diagnosis and prognosis of acute myocardial infarction.

Authors:  Tong Su; Xiaonan Shao; Xiaopu Zhang; Chengjian Yang; Xiaoliang Shao
Journal:  Int J Cardiol       Date:  2019-10-08       Impact factor: 4.164

8.  A Role for the Long Noncoding RNA SENCR in Commitment and Function of Endothelial Cells.

Authors:  Mounia Boulberdaa; Elizabeth Scott; Margaret Ballantyne; Raquel Garcia; Betty Descamps; Gianni D Angelini; Mairi Brittan; Amanda Hunter; Martin McBride; John McClure; Joseph M Miano; Costanza Emanueli; Nicholas L Mills; Joanne C Mountford; Andrew H Baker
Journal:  Mol Ther       Date:  2016-02-22       Impact factor: 11.454

Review 9.  Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease.

Authors:  Juliane C R Fernandes; Stephanie M Acuña; Juliana I Aoki; Lucile M Floeter-Winter; Sandra M Muxel
Journal:  Noncoding RNA       Date:  2019-02-17

10.  LncRNA-Safe contributes to cardiac fibrosis through Safe-Sfrp2-HuR complex in mouse myocardial infarction.

Authors:  Kaili Hao; Wei Lei; Hongchun Wu; Jie Wu; Zhuangzhuang Yang; Shiping Yan; Xing-Ai Lu; Jingjing Li; Xue Xia; Xinglong Han; Wenbo Deng; Guisheng Zhong; Zhen-Ao Zhao; Shijun Hu
Journal:  Theranostics       Date:  2019-09-25       Impact factor: 11.556

View more
  2 in total

Review 1.  Long Noncoding RNAs Involved in Cardiomyocyte Apoptosis Triggered by Different Stressors.

Authors:  Jinghui Sun; Ru Wang; Tiantian Chao; Chenglong Wang
Journal:  J Cardiovasc Transl Res       Date:  2021-12-02       Impact factor: 3.216

2.  Epigenetic modification mechanism of histone demethylase KDM1A in regulating cardiomyocyte apoptosis after myocardial ischemia-reperfusion injury.

Authors:  Lin He; Yanbo Wang; Jin Luo
Journal:  PeerJ       Date:  2022-08-05       Impact factor: 3.061

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.